Detalhe da pesquisa
1.
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans.
Cell
; 176(6): 1340-1355.e15, 2019 03 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30799037
2.
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]. / S3-Leitlinie: Lungenerkrankung bei Mukoviszidose Pseudomonas aeruginosa.
Pneumologie
; 2024 Feb 13.
Artigo
Alemão
| MEDLINE | ID: mdl-38350639
3.
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]. / Erratum: S3-Leitlinie: Lungenerkrankung bei Mukoviszidose Pseudomonas aeruginosa.
Pneumologie
; 2024 Feb 29.
Artigo
Alemão
| MEDLINE | ID: mdl-38423036
4.
[Patients with cystic fibrosis become adults : Treatment hopes and disappointments]. / Patienten mit zystischer Fibrose werden erwachsen : Therapeutische Hoffnungen und Enttäuschungen.
Internist (Berl)
; 60(1): 98-108, 2019 Jan.
Artigo
Alemão
| MEDLINE | ID: mdl-30627755
5.
Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis-A Single-Centre Prospective Observational Study.
Antibiotics (Basel)
; 12(4)2023 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37107096
6.
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy.
Front Pharmacol
; 14: 1180826, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37408761
7.
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.
Front Pharmacol
; 14: 1167407, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38026920
8.
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.
Front Pharmacol
; 14: 1207356, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37205908
9.
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis.
J Clin Invest
; 133(5)2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36701198
10.
Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: An international survey.
J Cyst Fibros
; 21(1): 136-142, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34332906
11.
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score.
Front Pharmacol
; 13: 877118, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35721187
12.
Clinical impact of levofloxacin inhalation solution in cystic fibrosis patients in a real-world setting.
J Cyst Fibros
; 20(6): 1035-1039, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34099405
13.
Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients.
Virulence
; 12(1): 2415-2429, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34546836
14.
[Therapy of cystic fibrosis - new drugs give hope]. / Therapie der Mukoviszidose neue Medikamente geben Hoffnung.
Dtsch Med Wochenschr
; 145(20): 1486-1489, 2020 10.
Artigo
Alemão
| MEDLINE | ID: mdl-33022731
15.
Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis.
Front Cell Infect Microbiol
; 10: 602836, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33553006
16.
Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.
Sci Rep
; 10(1): 18999, 2020 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33149181
17.
Urban Life as Risk Factor for Aspergillosis.
Front Cell Infect Microbiol
; 10: 601834, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33224902
18.
Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Front Cell Infect Microbiol
; 10: 601821, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33585274
19.
Gene-Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever.
Front Immunol
; 11: 716, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32655537
20.
[Many patients with cystic fibrosis have a better quality of life now]. / Viele Patienten mit Mukoviszidose haben jetzt eine bessere Lebensqualität.
MMW Fortschr Med
; 163(Suppl 1): 74-81, 2021 03.
Artigo
Alemão
| MEDLINE | ID: mdl-33950452